V. Weinberg

2.0k total citations
18 papers, 1.3k citations indexed

About

V. Weinberg is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, V. Weinberg has authored 18 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in V. Weinberg's work include Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (5 papers) and Genetic factors in colorectal cancer (3 papers). V. Weinberg is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (5 papers) and Genetic factors in colorectal cancer (3 papers). V. Weinberg collaborates with scholars based in United States and South Africa. V. Weinberg's co-authors include Scott Wadler, Edward L. Schwartz, Soonmee Cha, Nazia F. Jafri, Jennifer Clarke, Igor J. Barani, James F. Holland, Louis A. Leone, Matthew Zimmerman and P H Wiernik and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

V. Weinberg

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Weinberg United States 11 615 464 445 309 247 18 1.3k
Harriet Druker Canada 17 478 0.8× 338 0.7× 260 0.6× 553 1.8× 218 0.9× 23 1.6k
Francisco J. Martínez‐Tello Spain 21 485 0.8× 201 0.4× 361 0.8× 538 1.7× 232 0.9× 42 1.6k
Arthur K.C. Lee United States 13 696 1.1× 685 1.5× 192 0.4× 670 2.2× 453 1.8× 19 1.6k
Patrick R. Benusiglio France 15 515 0.8× 352 0.8× 413 0.9× 652 2.1× 263 1.1× 38 1.3k
Robert Königsberg Austria 16 676 1.1× 357 0.8× 165 0.4× 536 1.7× 220 0.9× 31 1.5k
Raja Luthra United States 24 526 0.9× 468 1.0× 310 0.7× 456 1.5× 367 1.5× 54 1.7k
Sabine C. Glöckner Germany 18 544 0.9× 550 1.2× 417 0.9× 1.6k 5.3× 223 0.9× 21 2.2k
Michela Manzotti Italy 18 548 0.9× 189 0.4× 411 0.9× 264 0.9× 78 0.3× 27 956
M. Linehan United States 12 332 0.5× 576 1.2× 633 1.4× 860 2.8× 144 0.6× 14 1.4k
Hanane Ouakrim France 13 1.5k 2.4× 243 0.5× 564 1.3× 371 1.2× 159 0.6× 16 2.2k

Countries citing papers authored by V. Weinberg

Since Specialization
Citations

This map shows the geographic impact of V. Weinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Weinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Weinberg more than expected).

Fields of papers citing papers by V. Weinberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Weinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Weinberg. The network helps show where V. Weinberg may publish in the future.

Co-authorship network of co-authors of V. Weinberg

This figure shows the co-authorship network connecting the top 25 collaborators of V. Weinberg. A scholar is included among the top collaborators of V. Weinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Weinberg. V. Weinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jafri, Nazia F., Jennifer Clarke, V. Weinberg, Igor J. Barani, & Soonmee Cha. (2012). Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro-Oncology. 15(1). 91–96. 163 indexed citations
2.
Choueiri, Toni K., S. A. Vaziri, Erich Jaeger, et al.. (2008). von Hippel-Lindau Gene Status and Response to Vascular Endothelial Growth Factor Targeted Therapy for Metastatic Clear Cell Renal Cell Carcinoma. The Journal of Urology. 180(3). 860–866. 166 indexed citations
3.
Rini, Brian I., Erich Jaeger, V. Weinberg, et al.. (2006). Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel‐Lindau gene status. British Journal of Urology. 98(4). 756–762. 87 indexed citations
4.
Learman, Lee A., et al.. (2004). Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management*. International Journal of Gynecological Cancer. 14(6). 1055–1062. 10 indexed citations
5.
Galsky, Matt D., et al.. (2004). Response to second-line taxane-based therapy after first-line epothilone B analogue BMS-247550 (BMS) therapy in hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology. 22(14_suppl). 4564–4564. 9 indexed citations
6.
Learman, Lee A., et al.. (2004). Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management. International Journal of Gynecological Cancer. 14(6). 1055–1062. 1 indexed citations
7.
Weinberg, V., et al.. (1996). Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.. Journal of Clinical Oncology. 14(7). 2073–2082. 111 indexed citations
8.
Wadler, Scott, Robert P. Wersto, V. Weinberg, Darren A. Thompson, & Edward L. Schwartz. (1990). Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects.. PubMed. 50(18). 5735–9. 114 indexed citations
9.
Wadler, Scott, Edward L. Schwartz, Marc Goldman, et al.. (1989). Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.. Journal of Clinical Oncology. 7(12). 1769–1775. 271 indexed citations
10.
Perloff, Michael, Gerson Lesnick, Florence C. H. Chu, et al.. (1988). Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study.. Journal of Clinical Oncology. 6(2). 261–269. 139 indexed citations
11.
Wood, William C., Raymond B. Weiss, Douglass C. Tormey, et al.. (1985). A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node‐positive stage II breast cancer: A CALGB study. World Journal of Surgery. 9(5). 714–718. 16 indexed citations
12.
Richards, Frederick, et al.. (1984). Phase II trial of amsacrine in patients with hepatoma: a Cancer and Leukemia Group B study.. PubMed. 68(6). 923–4. 4 indexed citations
13.
Tormey, Douglass C., V. Weinberg, Louis A. Leone, et al.. (1984). A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer A Cancer and Leukemia Group B study. American Journal of Clinical Oncology. 7(3). 231–240. 64 indexed citations
14.
Forastiere, Arlene A., D. R. Budman, Frederick Richards, et al.. (1983). Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.. PubMed. 67(12). 1137–8. 4 indexed citations
15.
Tormey, D C, V. Weinberg, James F. Holland, et al.. (1983). A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.. Journal of Clinical Oncology. 1(2). 138–145. 69 indexed citations
16.
Weiss, R B, D. C. Tormey, V. Weinberg, et al.. (1982). A Randomized Trial of Postoperative Five-Versus Three-Drug Chemotherapy After Mastectomy: A Cancer and Leukemia Group B (CALGB) Study. Recent results in cancer research. 80. 170–176. 5 indexed citations
17.
Budman, Daniel R., A. Forastiere, Michael Perloff, et al.. (1982). Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.. PubMed. 66(10). 1875–6. 4 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harriet Druker Breakdown of academic impact, for papers by Francisco J. Martínez‐Tello Breakdown of academic impact, for papers by Arthur K.C. Lee Breakdown of academic impact, for papers by Patrick R. Benusiglio Breakdown of academic impact, for papers by Robert Königsberg Breakdown of academic impact, for papers by Raja Luthra Breakdown of academic impact, for papers by Sabine C. Glöckner Breakdown of academic impact, for papers by Michela Manzotti Breakdown of academic impact, for papers by M. Linehan Breakdown of academic impact, for papers by Hanane Ouakrim
Rankless by CCL
2026